Tower Research Capital LLC (TRC) - ITERUM THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

ITERUM THERAPEUTICS PLC's ticker is and the CUSIP is G6333L200. A total of 15 filers reported holding ITERUM THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ITERUM THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$18
-47.1%
22
-31.2%
0.00%–
Q2 2023$34
+240.0%
32
-99.7%
0.00%–
Q1 2023$10
+150.0%
9,668
+119.7%
0.00%–
Q4 2022$4
-99.8%
4,401
+232.9%
0.00%–
Q3 2022$2,000–1,322–0.00%–
 Download
Other shareholders
ITERUM THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 97,084$77,6670.10%
NewEdge Advisors, LLC 100$800.00%
OSAIC HOLDINGS, INC. 24$190.00%
WELLS FARGO & COMPANY/MN 1,285$1,0290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HM PAYSON & CO 3$30.00%
MORGAN STANLEY 13,950$11,1740.00%
NATIONAL BANK OF CANADA /FI/ 2$20.00%
Citadel Advisors 19,566$16,2400.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 47,656$39,5540.00%
View complete list of ITERUM THERAPEUTICS PLC shareholders